Marie-Josée Dion

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 368 citations · Full text

Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

Dick Menzies, Richard Long, Anete Trajman et al. · Annals of Internal Medicine · 2008 · 188 citations

Treatment Completion and Costs of a Randomized Trial of Rifampin for 4 Months versus Isoniazid for 9 Months

Dick Menzies, Marie-Josée Dion, Barry Rabinovitch et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 170 citations

Feasibility and reliability of health-related quality of life measurements among tuberculosis patients

Marie-Josée Dion, Pierre Tousignant, Jean Bourbeau et al. · Quality of Life Research · 2004 · 69 citations

Reliability, Quality Of Life, Life Assessment +12

Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.

Anete Trajman, Richard Long, D Zylberberg et al. · PubMed · 2010 · 58 citations